All data are based on the daily closing price as of October 15, 2026
k

Kaneka

4118.TSE
38.20 USD
-0.23
-0.60%

Overview

Last close
38.20 usd
Market cap
2.29B usd
52 week high
39.86 usd
52 week low
23.59 usd
Target price
35.11 usd

Valuation

P/E
10.5012
Forward P/E
8.9047
Price/Sales
0.436
Price/Book Value
0.7205
Enterprise Value
3.41B usd
EV/Revenue
0.6632
EV/EBITDA
5.5913

Key financials

Revenue TTM
5.30B usd
Gross Profit TTM
1.50B usd
EBITDA TTM
549.41M usd
Earnings per Share
3.67 usd
Dividend
1.01 usd
Total assets
6.05B usd
Net debt
1.07B usd

About

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan, Asia, North America, Europe, and internationally. It offers impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymer, engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.
  • Symbol
    4118.TSE
  • Exchange
    TSE
  • Isin
    JP3215800008
  • Country
    Japan
  • Sector
    Basic Materials
  • Industry
    Specialty Chemicals
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.kaneka.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top